Medicare Enrolled
Dr. Yi Li, M.D.
Internal Medicine · Bakersfield, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Li from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Li?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Li
Dr. Yi Li is an internal medicine specialist in Bakersfield, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Li performed 110,698 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Li received a total of $21,105 from 37 pharmaceutical and/or device companies across 966 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Li is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 0% volume in CA
$21,105 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗110,698
Medicare services
Top 0% in CA for internal medicine
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 24,800 | $5 | $9 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
22,050 | $10 | $40 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
17,325 | $33 | $72 |
| Denosumab injection (Prolia/Xgeva) | 15,660 | $18 | $30 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
10,389 | $63 | $130 |
| Romosozumab injection (Evenity) for osteoporosis | 7,560 | $8 | $14 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
4,140 | $26 | $130 |
| Belimumab injection, 10 mg An injection of belimumab, a medication administered at a dose of 10 mg. |
3,841 | $40 | $80 |
| Injection, tildrakizumab, 1 mg | 2,200 | $110 | $180 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
693 | $111 | $300 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
407 | $24 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
349 | $82 | $200 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
324 | $12 | $50 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
304 | $13 | $60 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
186 | $62 | $125 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
131 | $4 | $20 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
123 | $1 | $10 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
79 | $8 | $20 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
55 | $6 | $70 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $133 | $250 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $46 | $150 |
| Injection, methylprednisolone acetate, 40 mg | 13 | $6 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
39.9% high complexity
59.7% medium
0.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,105
Total received (2019-2024)
Avg $3,517/year across 6 years
Top 6% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
966
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,994
2023
$3,786
2022
$3,833
2021
$3,858
2020
$4,294
2019
$340
Payments by company (2024)
ABBVIE INC.
$1,107
Amgen Inc.
$895
Janssen Biotech, Inc.
$638
Novartis Pharmaceuticals Corporation
$356
GlaxoSmithKline, LLC.
$260
ANI Pharmaceuticals, Inc.
$246
Lilly USA, LLC
$190
AstraZeneca Pharmaceuticals LP
$188
E.R. Squibb & Sons, L.L.C.
$181
Kiniksa Pharmaceuticals International, plc
$172
Mallinckrodt Hospital Products Inc.
$146
PFIZER INC.
$133
Aurinia Pharma U.S., Inc.
$118
Biocon Biologics Inc
$71
TerSera Therapeutics LLC
$66
Fresenius Kabi USA, LLC
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
UCB, Inc.
$38
SCILEX PHARMACEUTICALS INC.
$38
Fidia Pharma USA Inc.
$16
Alexion Pharmaceuticals, Inc.
$14
Teva Pharmaceuticals USA, Inc.
$14
Top 3 companies account for 52.9% of 2024 payments
All-time payments by company (2019-2024) ›
Amgen Inc.
$3,941
Janssen Biotech, Inc.
$2,676
ABBVIE INC.
$2,551
Horizon Therapeutics plc
$2,302
GlaxoSmithKline, LLC.
$1,457
Novartis Pharmaceuticals Corporation
$1,344
AstraZeneca Pharmaceuticals LP
$1,149
AbbVie Inc.
$882
Lilly USA, LLC
$613
E.R. Squibb & Sons, L.L.C.
$591
Genentech USA, Inc.
$523
ANI Pharmaceuticals, Inc.
$416
Janssen Scientific Affairs, LLC
$382
Aurinia Pharma U.S., Inc.
$371
Mallinckrodt Hospital Products Inc.
$351
PFIZER INC.
$203
Kiniksa Pharmaceuticals International, plc
$172
Boehringer Ingelheim Pharmaceuticals, Inc.
$138
Radius Health, Inc.
$137
GENZYME CORPORATION
$122
AbbVie, Inc.
$117
UCB, Inc.
$91
Fresenius Kabi USA, LLC
$87
Alexion Pharmaceuticals, Inc.
$78
Biocon Biologics Inc
$71
TerSera Therapeutics LLC
$66
Mallinckrodt Enterprises LLC
$55
SCILEX PHARMACEUTICALS INC.
$38
Organon LLC
$29
Ultragenyx Pharmaceutical Inc.
$23
Biohaven Pharmaceuticals, Inc.
$22
Pacira Therapeutics, Inc.
$20
Celgene Corporation
$19
Kiniksa Pharmaceuticals, Ltd.
$19
ARBOR PHARMACEUTICALS, INC.
$18
Fidia Pharma USA Inc.
$16
Teva Pharmaceuticals USA, Inc.
$14
Top 3 companies account for 43.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · Enbrel · FARXIGA · HUMIRA · HYMOVIS · Horizant · Hulio · Humira · IDACIO · KEVZARA · KRYSTEXXA · LUPKYNIS · NURTEC ODT · OFEV · ONTRUZANT · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPEVIGO · Strensiq · TALTZ · TAVNEOS · TEZSPIRE · TREMFYA · Truxima · Tymlos · ULTOMIRIS · UPLIZNA · Ultomiris · XELJANZ · ZTLido · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
233
County median income
$67,660
Nearest hospital to ZIP centroid (approximate)
BAKERSFIELD BEHAVIORAL HEALTHCARE HOSPITAL, LLC
4.6 mi
4.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Li is a mixed practice specialist, with above-average Medicare volume (top 0% in CA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Li experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Li performed 24,800 tocilizumab injection (actemra) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Li receive payments from pharmaceutical companies?
Yes. Dr. Li received a total of $21,105 from 37 companies across 966 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Li's costs compare to other internal medicine physicians in Bakersfield?
Dr. Li's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Li) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Bakersfield
Browse internal medicine physicians in Bakersfield ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology